TY  - JOUR
AU  - Garderet, Laurent
AU  - Cook, Gordon
AU  - Auner, Holger W
AU  - Bruno, Benedetto
AU  - Lokhorst, Henk
AU  - Perez-Simon, Jose Antonio
AU  - Sahebi, Firoozeh
AU  - Scheid, Christof
AU  - Morris, Curly
AU  - van Biezen, Anja
AU  - Sobh, Mohamad
AU  - Michallet, Mauricette
AU  - Gahrton, Gösta
AU  - Schönland, Stefan
AU  - Kröger, Nicolaus
PY  - 2016
DO  - 10.1080/10428194.2016.1228926
UR  - http://hdl.handle.net/10668/10465
T2  - Leukemia & lymphoma
AB  - Major improvements have been made in the treatment of myeloma. However, all patients, perhaps with some exceptions, eventually relapse, even after autologous stem cell transplantation (ASCT). In that setting, the combinations of new drugs, namely the...
LA  - en
KW  - Myeloma
KW  - allogeneic stem cell transplantation
KW  - autologous stem cell transplantation
KW  - immunomodulatory drugs
KW  - monoclonal antibodies
KW  - proteasome inhibitors
KW  - relapse
KW  - Combined Modality Therapy
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Multiple Myeloma
KW  - Recurrence
KW  - Retreatment
KW  - Transplantation, Autologous
TI  - Treatment options for relapse after autograft in multiple myeloma - report from an EBMT educational meeting.
TY  - research article
VL  - 58
ER  -